全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

早期目标导向镇静防治麻醉苏醒期躁动的研究进展
Research Progress of Early Goal-Directed Sedation in Prevention and Treatment of Emergence Agitation during Anesthesia Recovery Period

DOI: 10.12677/acm.2025.152398, PP. 708-715

Keywords: 早期目标导向镇静,苏醒期躁动,全身麻醉,复苏质量
Early Goal-Directed Sedation
, Emergence Agitation, General Anesthesia, Recovery Quality

Full-Text   Cite this paper   Add to My Lib

Abstract:

苏醒期躁动(EA)是全麻苏醒期的临床常见并发症之一,主要表现为定向功能和感知功能改变的、对自身环境的认知和关注能力的障碍。EA的整体发生率因各因素影响从0.25%到90.5%不等,如处理不当,可对患者自身和医护人员造成严重危害。而早期目标导向镇静(EGDS)理念有助于减弱或消除伤害性刺激诱发的不良后果,从而减少EA的发生率,使全麻患者的复苏过程更加平稳舒适。本文围绕EA的影响因素、危害,以及EGDS理念的优势、常用药物等方面展开论述,为改善全麻患者的复苏质量,减少EA的发生率提供参考。
Emergence agitation (EA) is one of the common complications during the recovery period after general anesthesia, primarily characterized by alterations in orientation and perceptual functions, leading to impaired cognitive and attentional abilities regarding one’s environment. The overall incidence of EA varies widely from 0.25% to 90.5% depending on various factors, and if not managed properly, it can pose serious risks to both patients and healthcare personnel. The concept of early goal-directed sedation (EGDS) can help mitigate or eliminate the adverse effects induced by harmful stimuli, thereby reducing the incidence of EA and making the recovery process for patients undergoing general anesthesia smoother and more comfortable. This article discusses the influencing factors and hazards of EA, as well as the advantages of the EGDS approach and commonly used medications, providing a reference for improving recovery quality in patients undergoing general anesthesia and reducing the incidence of EA.

References

[1]  Cho, H., Kim, J., Kim, D., Kim, D. and Chae, Y. (2012) Comparison of the Optimal Effect-Site Concentrations of Remifentanil for Preventing Cough during Emergence from Desflurane or Sevoflurane Anaesthesia. Journal of International Medical Research, 40, 174-183.
https://doi.org/10.1177/147323001204000118
[2]  Kim, E.S. and Bishop, M.J. (1998) Cough during Emergence from Isoflurane Anesthesia. Anesthesia & Analgesia, 87, 1170-1174.
https://doi.org/10.1213/00000539-199811000-00036
[3]  Fields, A., Huang, J., Schroeder, D., Sprung, J. and Weingarten, T. (2018) Agitation in Adults in the Post-Anaesthesia Care Unit after General Anaesthesia. British Journal of Anaesthesia, 121, 1052-1058.
https://doi.org/10.1016/j.bja.2018.07.017
[4]  Yu, D., Chai, W., Sun, X. and Yao, L. (2010) Emergence Agitation in Adults: Risk Factors in 2,000 Patients. Canadian Journal of Anesthesia/Journal canadien danesthésie, 57, 843-848.
https://doi.org/10.1007/s12630-010-9338-9
[5]  Choi, G.J., Baek, C.W., Kang, H., Park, Y.H., Yang, S.Y., Shin, H.Y., et al. (2014) Emergence Agitation after Orthognathic Surgery: A Randomised Controlled Comparison between Sevoflurane and Desflurane. Acta Anaesthesiologica Scandinavica, 59, 224-231.
https://doi.org/10.1111/aas.12435
[6]  Kanaya, A. (2015) Emergence Agitation in Children: Risk Factors, Prevention, and Treatment. Journal of Anesthesia, 30, 261-267.
https://doi.org/10.1007/s00540-015-2098-5
[7]  Sessler, C.N., Gosnell, M.S., Grap, M.J., Brophy, G.M., O'Neal, P.V., Keane, K.A., et al. (2002) The Richmond Agitation-Sedation Scale: Validity and Reliability in Adult Intensive Care Unit Patients. American Journal of Respiratory and Critical Care Medicine, 166, 1338-1344.
https://doi.org/10.1164/rccm.2107138
[8]  Riker, R.R., Picard, J.T. and Fraser, G.L. (1999) Prospective Evaluation of the Sedation-Agitation Scale for Adult Critically Ill Patients. Critical Care Medicine, 27, 1325-1329.
https://doi.org/10.1097/00003246-199907000-00022
[9]  Yu, D., Chai, W., Sun, X. and Yao, L. (2010) Emergence Agitation in Adults: Risk Factors in 2,000 Patients. Canadian Journal of Anesthesia/Journal canadien danesthésie, 57, 843-848.
https://doi.org/10.1007/s12630-010-9338-9
[10]  Saringcarinkul, A., Manchupong, S. and Punjasawadwong, Y. (2008) Incidence and Risk Factors of Emergence Agitation in Pediatric Patients after General Anesthesia. The Journal of the Medical Association of Thailand, 91, 1226-1231.
[11]  谢婷. 右美托咪定对老年骨折手术患者全身麻醉苏醒期躁动的影响[J]. 中国社区医师, 2021, 37(1): 44-45.
[12]  林俊, 马莉萍, 陈美华, 等. 小剂量丙泊酚对预防吸入全麻苏醒期呛咳反应的影响[J]. 中国医药导报, 2015(31): 119-122.
[13]  肖体松, 汪艳清, 邓海艳, 等. 右美托咪定在老年四肢骨折中的应用效果及对患者全身麻醉苏醒期躁动的影响[J]. 中国现代药物应用, 2021, 15(6): 190-192.
[14]  张庆华, 黄修海, 曹志云, 等. 帕瑞昔布钠与右美托咪定联用预防小儿全身麻醉苏醒期不良反应的效果探究[J]. 药品评价, 2017, 14(5): 33-36.
[15]  叶丽群, 何娟明, 植碧清, 等. 全身麻醉苏醒期应用右美托咪啶对胃部手术患者镇静的研究[J]. 吉林医学, 2017, 38(6): 1116-1117.
[16]  钟真良. 右美托咪定对腹部手术患者全身麻醉苏醒期呼吸、血流动力学、BIS值的影响[J]. 职业卫生与病伤, 2016, 31(2): 111-115.
[17]  王鑫凯, 张君婷, 任韧. 早期目标导向镇静对腹腔镜下肾切除老年患者术后谵妄的影响研究[J]. 中文科技期刊数据库(全文版)医药卫生, 2020(10): 2.
[18]  Shehabi, Y., Bellomo, R., Reade, M.C., Bailey, M., Bass, F., Howe, B., et al. (2013) Early Goal-Directed Sedation versus Standard Sedation in Mechanically Ventilated Critically Ill Patients: A Pilot Study. Critical Care Medicine, 41, 1983-1991.
https://doi.org/10.1097/ccm.0b013e31828a437d
[19]  杨贵荣, 郭晓东, 毛更生, 等. 早期目标导向镇静对急性脑损伤患者脑氧代谢的影响[J]. 中华危重病急救医学, 2021, 1(33): 79-83.
[20]  王颖, 朱浩, 顾维立, 等. 早期目标导向镇静与标准镇静对重症机械通气患者预后及出科后心理状况的比较[J]. 临床急诊杂志, 2018, 19(5): 294-298.
[21]  蓝天, 翟芳芳. 常规镇静与早期目标导向镇静对急性脑损伤患者脑氧代谢的影响分析[J]. 大医生, 2022, 7(18): 77-79.
[22]  杨贵荣, 郭晓东, 毛更生, 等. 早期目标导向镇静在急性脑损伤中的应用[J]. 中华危重病急救医学, 2020, 32(3): 345-349.
[23]  陈英, 胡亚兰, 陈慧娟, 等. 早期目标导向镇静与标准化镇静对肾移植术机械通气患者撤机的比较[J]. 世界最新医学信息文摘(连续型电子期刊), 2015(45): 1-2.
[24]  黄洁, 蒋文琛. 丙泊酚对腹腔镜下子宫肌瘤剔除术患者全身麻醉苏醒期躁动的影响[J]. 中国药业, 2016, 25(19): 50-53.
[25]  邓韦韦. 术中丙泊酚麻醉维持对全子宫切除术患者麻醉苏醒期及术后认知功能的影响[J]. 河北医学, 2018, 24(10): 1647-1651.
[26]  王宏, 靳天, 刘刚, 等. 右美托咪定或丙泊酚联合七氟烷维持麻醉对小儿苏醒期躁动的影响[J]. 上海医学, 2015, 38(8): 639-642.
[27]  强丽宁, 呼霞. 右美托咪定和丙泊酚治疗全麻后苏醒期躁动的疗效分析[J]. 中国医药导刊, 2015, 17(8): 801-802, 809.
[28]  Qin, L., Ren, L., Wan, S., Liu, G., Luo, X., Liu, Z., et al. (2017) Design, Synthesis, and Evaluation of Novel 2, 6-Disubstituted Phenol Derivatives as General Anesthetics. Journal of Medicinal Chemistry, 60, 3606-3617.
https://doi.org/10.1021/acs.jmedchem.7b00254
[29]  Lu, M., Liu, J., Wu, X. and Zhang, Z. (2023) Ciprofol: A Novel Alternative to Propofol in Clinical Intravenous Anesthesia? BioMed Research International, 2023, Article ID: 7443226.
https://doi.org/10.1155/2023/7443226
[30]  陈峻, 黄格, 马树兴, 等. 环泊酚在老年泌尿系手术患者全身麻醉诱导中的有效性和安全性[J]. 临床合理用药, 2023, 16(24): 103-106.
[31]  高飞, 崔博群, 马骏. 环泊酚和依托咪酯在非体外循环冠状动脉旁路移植术中的抗氧化应激作用比较[J]. 中国医药, 2023, 18(8): 1136-1139.
[32]  朱锋, 邓义江, 周再银, 等. 环泊酚与丙泊酚的药效动力学特性比较[J]. 中外医学研究, 2023, 21(24): 1-5.
[33]  Yu, L., Bischof, E. and Lu, H. (2023) Anesthesia with Ciprofol in Cardiac Surgery with Cardiopulmonary Bypass: A Case Report. World Journal of Clinical Cases, 11, 157-163.
https://doi.org/10.12998/wjcc.v11.i1.157
[34]  Liang, P., Dai, M., Wang, X., Wang, D., Yang, M., Lin, X., et al. (2023) Efficacy and Safety of Ciprofol vs. Propofol for the Induction and Maintenance of General Anaesthesia. European Journal of Anaesthesiology, 40, 399-406.
https://doi.org/10.1097/eja.0000000000001799
[35]  Li, J., Wang, X., Liu, J., Wang, X., Li, X., Wang, Y., et al. (2022) Comparison of Ciprofol (HSK3486) versus Propofol for the Induction of Deep Sedation during Gastroscopy and Colonoscopy Procedures: A Multi‐Centre, Non‐Inferiority, Randomized, Controlled Phase 3 Clinical Trial. Basic & Clinical Pharmacology & Toxicology, 131, 138-148.
https://doi.org/10.1111/bcpt.13761
[36]  Yang, Y., Xia, Z., Xu, C., Zhai, C., Yu, X. and Li, S. (2022) Ciprofol Attenuates the Isoproterenol-Induced Oxidative Damage, Inflammatory Response and Cardiomyocyte Apoptosis. Frontiers in Pharmacology, 13, Article 1037151.
https://doi.org/10.3389/fphar.2022.1037151
[37]  谭正玲, 彭姝嫕, 胡志强, 等. 环泊酚用于肥胖患者宫腔镜手术麻醉的安全性及有效性[J]. 广东医学, 2023, 44(4): 462-466.
[38]  王如, 蔺祎, 王益敏, 等. 环泊酚与丙泊酚用于日间宫腔镜手术的麻醉效果比较[J]. 广东医学, 2023, 44(2): 188-193.
[39]  Bian, Y., Zhang, H., Ma, S., Jiao, Y., Yan, P., Liu, X., et al. (2020) Mass Balance, Pharmacokinetics and Pharmacodynamics of Intravenous HSK3486, a Novel Anaesthetic, Administered to Healthy Subjects. British Journal of Clinical Pharmacology, 87, 93-105.
https://doi.org/10.1111/bcp.14363
[40]  黄凤南, 徐城, 崔珊珊, 等. 环泊酚单药与联合小剂量舒芬太尼在无痛胃镜检查中的麻醉效果比较[J]. 武汉大学学报(医学版), 2023, 44(5): 585-589.
[41]  史金麟, 徐帆, 甘建辉, 等. 小剂量艾司氯胺酮联合环泊酚在老年患者无痛胃肠镜检查中的临床应用[J]. 实用医院临床杂志, 2023, 20(1): 40-43.
[42]  刘璐. 环泊酚与小剂量右美托咪定复合麻醉对腹腔镜下子宫肌瘤切除术麻醉效果及术后应激反应的影响[J]. 实用妇科内分泌电子杂志, 2022, 9(19): 72-74.
[43]  Kim, J.C., Kim, J., Kwak, H. and Ahn, S.W. (2019) Premedication with Dexmedetomidine to Reduce Emergence Agitation: A Randomized Controlled Trial. BMC Anesthesiology, 19, Article No. 144.
https://doi.org/10.1186/s12871-019-0816-5
[44]  Hauber, J.A., Davis, P.J., Bendel, L.P., Martyn, S.V., McCarthy, D.L., Evans, M., et al. (2015) Dexmedetomidine as a Rapid Bolus for Treatment and Prophylactic Prevention of Emergence Agitation in Anesthetized Children. Anesthesia & Analgesia, 121, 1308-1315.
https://doi.org/10.1213/ane.0000000000000931
[45]  Chen, Z., Chen, Y., Guo, Y., et al. (2013) [Effect of Dexmedetomidine on Emergence Agitation after Oral and Maxillofacial Surgery]. Shanghai Journal of Stomatology, 22, 698-701.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133